Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Year 5 - Obstetrics and Gynaecology > Ovarian tumour (benign and malignant) > Flashcards

Ovarian tumour (benign and malignant) Flashcards

1
Q

What are the different types of ovarian tumours?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the most common type of ovarian cancer?

A

Epithelial ovarian cancer (~90% of cases) - develops when there is malignant transformation of the epithelium covering the ovarian capsule and distal fallopian tube

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

When does ovarian cancer usually occur?

A

Peak age of incidence is 60 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Why does ovarian cancer generally carry a poor prognosis?

A

Due to late diagnosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What subtype of ovarian epithelial cancer is most common?

A

Serous carcinomas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Where is the origin of most ‘ovarian’ cancers?

A

Distal end of the fallopian tube

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the risk factors for ovarian cancer?

A

FH - mutations in BRCA1 and BRCA2

Many ovulations - early menarche, lane menopause, nulliparity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Which medication reduces the risk of ovarian cancer?

A

COCP -as it reduces the number of ovulations. NB: IVF does not increase risk.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What other factors decrease risk of ovarian cancer?

A
  • Multiparity
  • Tubal ligation
  • Salpingectomy
  • Hysterectomy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the clinical features of ovarian cancer?

A
  • abdominal distension and bloating
  • abdominal and pelvic pain
  • urinary symptoms e.g. Urgency
  • early satiety and difficulty eating
  • diarrhoea
  • other: change in bowel habit, urinary symptoms, back ache, irregular bleeding, fatigue

Most are vague, non-specific symptoms which may cause them to present in late-stage disease. 66% present with stage 3 or later.

O/E: fixed, hard mass arising from pelvis. Ascites makes ovarian cancer likely. Check for lymphadenopathy in groin and neck.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What tumour marker is commonly found in ovarian cancer? When should it be used? What level is significant?

A

CA125 - should NOT be used in asymptomatic women for screening.

Levels of _>_35 IU/mL mean an urgent scan of the abdomen and pelvis is required

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the non-malignant causes of a raised CA125?

A
  • Endometriosis
  • Menstruation
  • Benign ovarian cysts
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What investigations should be done for ovarian cancer?

A
  • CA125 - _>_35IU/mL significant and needs USS. Raised in 80% of epithelilal ovarian cancers.
  • USS - characterises the mass in terms of size, consistency, presence of solid elements, bilaterality, ascites, extraovarian disease e.g. peritoneal thickening and omental deposits.
    • –> CT/MRI - used for staging and assessing operability
  • Laparotomy - usually required for diagnosis
  • Paracentesis/pleural aspiration - symptom relief/cytological assessment

Pre-operatively:

  • ECG
  • CXR
  • FBC
  • U&E
  • LFTs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How is the RMI calculated? What is its use?

A

The Risk of Malignancy Index (RMI) is calculated from:

  • menopausal status,
  • pelvic ultrasound features
  • CA125

Used to triage pelvic masses into those at low, intermediate and high risk of malignancy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How is ovarian cancer staged?

A

FIGO staging system

  • 20% present with stage 1
  • 10% present with stage 2
  • 50% present with stage 3
  • 15% present with stage 4
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Where does metastatic spread occur to in ovarian cancer?

A

Direct spread –> peritoneum, other organs

Lymphatic spread –> pelvic and para-aortic nodes

18
Q

What is the management of ovarian cancer?

A

Usually a combination of surgery and platinum-based chemotherapy(with paclitaxel)

Following surgery all patients are discussed at MDT to see whether chemotherapy is necessary.

NB: the surgery and sampling of sites is necessary for diagnosis, staging and treatment.

19
Q

What is a side-effect of paclitaxel containing chemotherapy used in ovarian cancer?

A

Action: Derived from the bark of the Pacific yew and works by causing microtubular damage to the cell. This prevents replication and cell division.

SE: peripheral neuropathy, neutropenia and myalgia are common and dose dependent. Paclitaxol causes total loss of all body hair, irrespective of dose.

20
Q

How can you monitor for ovarian cancer recurrence?

A

Measure CA125 - levels start to rise prior to onset of clinical evidence of disease recurrence but treating the rising CA125 alone does not improve survival.

21
Q
A
22
Q

What is the prognosis with ovarian cancers? What are the 4 most important prognostic factors in ovarian cancer?

A

Overall 5-year survival is 46%

Most important prognostic factors:

  1. Age at presentation
  2. Stage of disease
  3. Histological type and grade
  4. Volume of residual disease post-surgery
23
Q

What is a Krukenberg tumour?

A

Ovarian metastases associated with primary cancers of the colon, stomach and breast.

24
Q

How are epithelial tumours classified based on risk of malignancy?

A
  • Benign
  • Malignant
  • Borderline - make up 10% and called borderline epithelial tumours (BOTs).
25
Q

What are the histological features of borderline epithelial tumours? Where do they spread?

A
  • Well differentiated
  • Some features of malignancy (nuclear pleomorphism, cellular atypia)
  • Do not invade the basement membare
  • Most are serous tumours

Spread to omentum and peritoneum but do not recur after initial surgery.

26
Q

What are the subtypes of epithelial ovarian cancers, from most to least common?

A
  • High-grade serous carcinomas
  • Micinous and endometrioid tumours
  • Clear cell carcinomas
27
Q

What is a characteristic histological feature of high-grade serous tumours of the ovary?

A

‘Psammoma bodies’ - concentric rings of calcification

28
Q

Which epithalial ovarian tumour can cause pseudomyxoma peritoneii? Describe their appearance.

A

Mucinous carcinoma- they are large multiloculated tumours

29
Q

Describe the appearance of endometrioid ovarian carcinomas.

A

Similar in histological appearance to endometriosis

Tend to be well differentiated and are associated with a better survival than high-grade serous carcinomas

30
Q

Which epithelial ovarian cancer other than endometrioid, can also arise from endometriosis?

A

Clear cell carcinoma - characterised by presence of clear cells

31
Q

What are fallopian tubal precursor lesions for high grade serous pelvic carcinomas called? What mutations do these have?

A

serous tubal intraepithelial carcinoma (STIC)

p53 and as many as 30% of high-grade pelvic serous cancers have BRCA mutations

32
Q

What mutations do endometriosis associated cancers usually contain?

A

Driver mutations in KRAS, PTEN, BRAF and ARID1A (rather than TP53)

33
Q

Why is ‘incessant ovulation’ hypothesised to increase risk of ovarian cancer?

A

The ‘incessant ovulation’ theory holds that the repeated damage to the ovarian surface epithelium that occurs at ovulation increases the risk of mutations that drive ovarian carcinogenesis.

Excess gonadotrophin secretion is also thought to drive tumorigenesis through oestrogen-stimulated epithelial proliferation and subsequent malignant transformation

34
Q

Which genetic conditions increase risk of ovarian cancer? When do cancer usually occur in these conditions?

A

10-15% have a genetic predisposition which may include:

  • Breast ovarian cancer syndrome (BRCA) - BRCA1 and BRCA2 mutations. Account for 90% of hereditary cancers.
  • Lynch syndrome (HNPCC) - also associated with endometrial cancer and 10% lifetime risk of ovarian cancer.
  • Risk of ovarian cancer increases from background 1.4% to 5% in the presence of these mutations.*
  • Occurs 10 years before sporadic cancers.*
35
Q

IS BRCA1 or BRCA2 more common in breast ovarian cancer syndrome? Which tends to cause cancer earlier?

A

BRCA1(80%) - mid 30s

BRCA2 (15%) - mid 40s

These are tumour suppressor genes

36
Q

Which type of ovarian cancer do hereditary conditions tend to be associated with?

A

Adenocarcinomas (with the exception of Lynch-associated tumours)

37
Q

What measures are taken to prevent ovarian cancer in BRCA mutation carriers?

A
  1. Prophylactic BSO- once completed family. Reduces ovarian cancer risk by 90% and breast by 50%.
  2. Chemoprevention - using COCP reduces ovarian cancer risk by up to 50%

NB: TVUSS and CA125 measurement has not been shown to improve survival in those with FH of ovarian cancer.

38
Q

What is a primary peritoneal carcinoma?

A

High grade pelvic serous carcinoma - histologically indistinct from tumours arising from the Fallopian tube or ovary but there are differences based on findings at laparotomy:

  1. Normal sized ovaries
  2. More extraovarian disease than ovarian disease
  3. Low volume peritoneal disease
39
Q

How do sex-cord stromal ovarian tumours present? What are the types?

A

Account for 10% of ovarian tumours, but 90% of functional ovarian tumours.

Oestrogen producing types:

  • Granulosa - most common (70%)
  • Theca
  • Sertoli

Androgen producing types:

  • Sertoli-Leydig
  • Steroid cell

Complications:

  • Precocious puberty - juvenile granulosa cell tumours (<10 years)
  • Abnormal menstrual bleeding
  • Androgen –> virilisation, amenorrhoea, deep voice, hirsutism, HTN
  • Increased risk of endometrial cancer
  • Peak incidence around menopause
40
Q

How do ovarian germ cell tumours present?

A

Derived from primordial germ cells within ovary - contain any cell type.

Pelvic mass or acutely with torsion (10%) or haemorrhage . Often in girls/young women. MRI useful for diagnosis. CXR should be done to exclude pulmonary metastases.

  1. Dysgerminomas (50%) - may secrete hCG
  2. Endodermal sinus yok sac tumours (15%) - may secrete AFP, spread to lungs
  3. Immature teratomas (15-20% of all malignant germ cell tumours and 1% of all teratomas) - mature or immature based on presence of neural tissue, may secrete AFP (33%), can undergo mailgnant transformation to epithelial carcinoma (SCC).
  4. Non-gestational choriocarcinoma - young girls with irregular bleeding and very high hCG

Year 5 - Obstetrics and Gynaecology (87 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions